Monash University, Department of Pharmacology, Centre for Vascular Health, Melbourne, Australien.
Dtsch Arztebl Int. 2009 Oct;106(42):677-84. doi: 10.3238/arztebl.2009.0677. Epub 2009 Oct 16.
Radicals have important physiological functions, for example, in immune defense and vasoprotection. However, they are also potentially dangerous waste products of cellular metabolism and they can contribute to the development of many different diseases.
Selective literature review.
The scientific understanding of radicals has not yet led to any therapeutic application. For many years, scavenging already formed radicals with antioxidants was considered to be the most promising therapeutic approach, but clinical trials based on this principle have yielded mostly negative results. Thus, entirely new approaches are needed. The goal should be to prevent the formation of harmful radicals, or to treat radical-related damage if it has already occurred. New diagnostic tools have the potential to identify those patients that are most likely to benefit from this form of treatment, as well as to document its success.
A new generation of cardiovascular drugs is being developed for the prevention or the mechanism-based treatment of vascular damage caused by oxidative stress. This new therapy should go hand in hand with new diagnostics, in accordance with the principle of individualized medicine.
自由基具有重要的生理功能,例如在免疫防御和血管保护方面。然而,它们也是细胞代谢过程中潜在的危险废物产物,可能导致许多不同的疾病。
选择性文献回顾。
对自由基的科学认识尚未导致任何治疗应用。多年来,用抗氧化剂清除已经形成的自由基被认为是最有前途的治疗方法,但基于这一原理的临床试验大多得出了负面结果。因此,需要全新的方法。目标应该是防止有害自由基的形成,或者在已经发生自由基相关损伤时进行治疗。新的诊断工具有可能识别出最有可能从这种治疗形式中受益的患者,并记录其疗效。
正在开发新一代心血管药物,以预防或针对由氧化应激引起的血管损伤进行基于机制的治疗。这种新疗法应该与新的诊断方法一起使用,遵循个体化医学的原则。